Role of interferon‐γ and inflammatory monocytes in driving colonic inflammation during acute Clostridium difficile infection in mice by McDermott, Andrew J. et al.
Role of interferon-c and inflammatory monocytes in driving colonic
inflammation during acute Clostridium difficile infection in mice
Andrew J. McDermott,1
Nicole R. Falkowski,2
Roderick A. McDonald,2
Charles R. Frank,2
Chinmay R. Pandit,2
Vincent B. Young1,3 and
Gary B. Huffnagle1,2
1Department of Microbiology and Immunology,
University of Michigan Medical School, Ann
Arbor, MI, 2Division of Pulmonary and
Critical Care Medicine, Department of Internal
Medicine, University of Michigan Medical
School, Ann Arbor, MI, and 3Division of
Infectious Diseases, Department of Internal
Medicine,University of Michigan Medical
School, Ann Arbor, MI, USA
doi:10.1111/imm.12700
Received 19 August 2016; revised 30
November 2016; accepted 5 December 2016.
Correspondence: Dr Gary B. Huffnagle,
6220, MSRB III, 1150 W. Medical Center
Drive, Ann Arbor, MI 48109-5642, USA.
Email: ghuff@umich.edu
Senior author: Gary B. Huffnagle
Summary
The inflammatory response to the colonic pathogen Clostridium difficile is
characterized by the induction of inflammatory cytokines including Inter-
leukin-23 (IL-23) and interferon-c (IFN-c) and the recruitment of myeloid
cells including Ly6CHigh monocytes. IL-23 knockout mice showed reduced
expression of the monocyte chemokines Ccl4 and Ccl7, but not Ccl2, as
well as reduced Ly6CHigh Ly6GMid monocyte recruitment to the colon in
response to C. difficile colitis. Clostridium difficile-infected CCR2/
(CCR2 KO) mice showed a significant defect in Ly6CHigh Ly6GMid mono-
cyte recruitment to the colon in response to C. difficile. Although there
was no decrease in expression of the inflammatory cytokines Il1b, Il6 or
Tnf or reduction in the severity of colonic histopathology associated with
ablation of monocyte recruitment, Slpi and Inos expression was signifi-
cantly reduced in the colons of these animals. Additionally, neutralization
of IFN-c through the administration of anti-IFN-c monoclonal antibody
resulted in a significant reduction in the expression of the IFN-c-inducible
chemokines Cxcl9 and Cxcl10, but not a reduction in the neutrophil
chemokines Cxcl1, Cxcl2 and Ccl3 or the monocyte chemokine Ccl2. Con-
sistently, monocyte and neutrophil recruitment were unchanged following
anti-IFN-c treatment. Additionally, Inos and Slpi expression were
unchanged following anti-IFN-c treatment, suggesting that Inos and Slpi
regulation is independent of IFN-c during C. difficile colitis. Taken
together, these data strongly suggest that IL-23 and CCR2 signalling are
required for monocyte recruitment during C. difficile colitis. Additionally,
these studies also suggest that monocytes, but not IFN-c, are necessary
for full expression of Inos and Slpi in the colon.
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Introduction
Monocyte-derived cells are key mediators of inflamma-
tory responses in the gastrointestinal tract.1 Monocyte
recruitment is often associated with the development of
inflammation and epithelial damage at mucosal sites.2–9
Monocytes and macrophages contribute to tumour
necrosis factor-a (TNF-a) production during both pul-
monary and colonic inflammation.6,7 Monocyte recruit-
ment is also required for full production of
inflammatory cytokines including interleukin-1b (IL-1b)
and IL-6, during dextran sulphate sodium (DSS) colitis.9
Furthermore, the development of intestinal histopathol-
ogy during DSS colitis is partially dependent on mono-
cyte recruitment.8,9
Clostridium difficile infection in mice results in innate
large bowel inflammation, characterized by increased
inflammatory cytokine expression, marked histopathol-
ogy, and rapid, robust recruitment of innate immune cells
including monocytes to the large bowel.2–5,10–18 MyD88
signalling is crucial for monocyte recruitment to the large
intestine in response to C. difficile colitis, and CCR2-defi-
cient mice show a significant defect in monocyte recruit-
ment when challenged with C. difficile.10 Studies suggest
that monocyte recruitment to the large intestine is not
required for host survival during C. difficile colitis,10 but
the role of recruited monocytes in promoting inflamma-
tory cytokine expression and epithelial damage, as well as
the host signals driving monocyte recruitment during
C. difficile colitis, remain poorly understood.
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Interferon-c (IFN-c) is a potent mediator of innate
inflammation at mucosal sites, including in the gastroin-
testinal tract.19–21 Interferon-c signalling is required for
full recruitment of neutrophils and production of
CXCL1 in response to Streptococcus pneumoniae infection
in the lung.20 Interferon-c is also required for CCL2 pro-
duction and neutrophil recruitment to the colon during
chemically induced colitis.19 Furthermore, recruited neu-
trophils produce IFN-c in response to both C. difficile15
and Salmonella typhimurium22 infection. Specific to the
host response to C. difficile, Ishida et al. reported
reduced TNF-a and CXCL1 expression in IFN-c knock-
out (KO) mice following administration of C. difficile
Toxin-A to ligated ileal loops.21 Consistently, numerous
studies from our own laboratory have reported increased
IFN-c expression in the colonic mucosa in response to
C. difficile infection.5,11,23 Additionally, a recent study by
Abt et al. has suggested a critical role for IFN-c-produ-
cing type I innate lymphoid cells in mediating host sur-
vival during C. difficile colitis.24 However, the role of
IFN-c in modulating innate inflammatory responses,
especially myeloid cell recruitment and inflammatory
cytokine and chemokine expression in response to infec-
tion with metabolically active C. difficile, is largely
unknown.
Interleukin-23 is a known driver of innate inflamma-
tion at mucosal sites.25,26 It drives inflammatory myeloid
cell recruitment to the lung in response to chemical27
and microbial28 challenge. Additionally, IL-23 is required
for the recruitment of inflammatory monocytes to the
spleen in response to Listeria monocytogenes infection.29
Furthermore, CD11bHigh myeloid cell recruitment is
markedly ablated during chemically induced colitis in
the absence of IL-23 signalling.25 Work by Buonomo
et al. has suggested a clear role for IL-23 in promoting
severe outcomes during experimental C. difficile infec-
tion,18 and recent studies from our laboratory have
demonstrated a role for IL-23 in driving neutrophil
recruitment and contributing to colonic histopathology
during C. difficile infection.26 However, the role of IL-23
in driving the recruitment of other myeloid populations
during C. difficile colitis, including monocytes, is poorly
understood.
In the current study, our initial goal was to determine
the role of IL-23 in driving Ly6CHigh Ly6GMid monocyte
recruitment to the large intestine during C. difficile colitis.
Having demonstrated reduced monocyte recruitment in
IL-23 KO mice, we next sought to determine if ablation
of CCR2-dependent monocyte recruitment alone was suf-
ficient to ameliorate the severity of colonic inflammatory
gene expression or colonic histopathology. Additionally,
recent studies have suggested a role for IFN-c in mediat-
ing host protection during C. difficile infection,24 but the
role of IFN-c in driving innate inflammatory responses to
C. difficile colitis remains poorly understood. As such, we
investigated the role of IFN-c signalling in driving neu-
trophil and monocyte recruitment, inflammatory cytokine
expression, and colonic histopathology during acute
C. difficile colitis in mice. Collectively, these studies reveal
the role of IL-23 in driving monocyte recruitment during
C. difficile infection, as well as identify the roles of CCR2-
dependent monocyte recruitment and IFN-c in driving
inflammatory cytokine expression, colonic histopathology,
and inflammatory myeloid cell recruitment during acute
C. difficile colitis.
Materials and methods
Animals and housing
C57BL/6 male mice aged 5–12 weeks from a colony
maintained at the University of Michigan founded by
Jackson breeders were used in the current study. Male
and female CCR2/ (CCR2KO) and p19/ (IL-23KO)
mice on a C57BL/6 background aged 5–14 weeks were
used in the current study. Both CCR2KO and IL-23KO
mice were obtained from in-house breeding colonies at
the University of Michigan. All mice were permitted
autoclaved water and food ad libitum, and were main-
tained under specific pathogen-free conditions with auto-
claved bedding. All animal manipulations were performed
in a laminar flow hood, and all experiments were per-
formed in accordance with a protocol approved by the
University Commission on the Use and Care of Animals
at the University of Michigan.
Bacterial culture and growth conditions
Clostridium difficile spores were prepared for infection as
previously described.11,26 Briefly, an existing spore stock
of C. difficile strain VPI 10463 was plated on Tauro-
cholate Cefoxitin Cycloserine Fructose Agar and cultured
overnight to generate vegetative cells. An individual col-
ony was used to inoculate an overnight culture in
Columbia broth. This overnight culture (2 ml) was then
used to inoculate 40 ml of Clospore30 sporulation med-
ium, and the culture was then allowed to grow for
7 days at 37° anaerobically. Spores were recovered by
washing the resulting pellet at least four times to remove
residual vegetative cells. Stocks were stored at 4° in water
until use.
Quantification of C. difficile colonization
Mucosal C. difficile colonization was assessed as described
previously4,11,31,32 using a C. difficile-specific PCR of
DNA isolated from host colonic tissue. Reaction volumes,
cycling conditions, and primer and probe sequences are
identical to those used previously.4,31,32 Raw Ct values
were normalized to a single copy per genome host gene
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used as an internal control to generate dCt values.32,33
Normalized dCt values were then converted to ‘C. difficile
genomes per gram of host tissue’ using a standard curve
developed using known quantities of host tissue and veg-
etative C. difficile.
Antibiotic treatment and infection
For all experiments, animals were given cefoperazone
(Sigma, St Louis, MO) at a concentration of 05 g/l in
their drinking water for 5 days as described previ-
ously.11,13,23,26 After the antibiotic treatment, mice were
permitted a 2-day recovery period on regular drinking
water before infection with C. difficile. Untreated animals
received neither C. difficile challenge nor antibiotic pre-
treatment.
For C. difficile infection studies, mice received approx-
imately 106 colony-forming units of VPI 10463 spores
by oral gavage on Day 0. Infected animals were moni-
tored for any sign of undue stress including lethargy,
hunched posture and weight loss exceeding 20% of
baseline body weight, and any moribund animals were
humanely killed. All experimental samples were collected
on Day 2.
Neutralizing antibody
In order to neutralize IFN-c in vivo, mice were given
500 lg of anti-IFN-c monoclonal antibody (clone
XMG.1.2) via intraperitoneal injection 1 day before and
1 day after infection (Day –1 and Day 1, respectively).
Colonic leucocyte isolation
Leucocytes were isolated from colonic tissue as described
previously,4,5,23,26,34 with certain modifications. Briefly,
colonic tissue was excised and physically disrupted using
serrated scissors. Minced tissue was then incubated in
20 ml of Hanks’ balanced salt solution (HBSS) supple-
mented with 1 mM dithiothreitol, 5 mM EDTA, and 25%
fetal calf serum for 20 min at 37°. Tissue was then
washed, and subsequently incubated with 20 ml of HBSS
supplemented with 05 mg/ml DNase (Roche, Basel,
Switzerland), 400 U/ml collagenase type 3 (Worthington
Biochemicals, Lakewood, NJ), and 25% fetal calf serum
for 1 hr at 37°. After washing, samples were then resus-
pended in 20% Percol (Sigma) in PBS and spun at 900 g
for 30 min without brake. The resulting single cell sus-
pension was stained for surface marker expression by flow
cytometry.
Flow cytometry staining and analysis
Flow cytometry staining was performed as described pre-
viously.4,5,23,26 Briefly, cells were plated at a concentration
of approximately 106 cells per well in a 96-well plate, and
were blocked with unlabelled FcRIII/II. After blocking,
cells were stained with fluorescently labelled antibodies
for 30 min at 4°. Cells were washed, and resuspended in
stabilizing fixative (BD Biosciences, Franklin Lakes, NJ).
All samples were acquired on a three-laser FACSCanto II
using FACS-DIVA software (BD Biosciences, Franklin
Lakes, NJ). All data analysis was performed in FLOWJO
(Treestar, Ashland, OR). Cells were stained with the fol-
lowing antibody clones: CD45 (clone 30-F11), CD11c
(clone HL3), CD11b (clone M1/70), Ly6C (clone AL-21),
and Ly6G (clone 1A8). All antibodies were purchased
from BD Biosciences or Biolegend (San Diego, CA).
For calculating number of CD11bHigh CD11cLow cells per
100 000 events, the frequency of CD45+ events was multi-
plied by the frequency of CD11bHigh CD11cLow events, and
the resulting number was multiplied by 100 000.
For calculating the number of Ly6CHigh Ly6GMid
monocytes or Ly6CMid Ly6GHigh neutrophils per 100 000
events, the frequency of CD45+ events was multiplied by
the frequency of CD11bHigh CD11cLow events, and the
frequency of either Ly6CHigh Ly6GMid monocytes or
Ly6CMid Ly6GHigh neutrophils. The resulting number was
then multiplied by 100 000..
The gating strategy for identification and enumeration
of colonic leucocyte subsets is also highlighted in the
Supplementary material (Fig. S1).
Preparation and examination of colonic histological sections
Excised colonic tissue was prepared for histological analy-
sis as described previously.4,5,11,23,26 Colonic tissue was
fixed in 10% formalin for a minimum of 24 hr and then
transferred to 70% ethanol. Cassettes were processed,
paraffin-embedded, sectioned and used to prepare haema-
toxylin and eosin stained slides by McClinchey Histology
Lab. Inc. (Stockbridge, MI).
Representative photomicrographs were acquired using
an Olympus BX40 light microscope (Olympus corpora-
tion, Tokyo, Japan) using a QImaging MicroPublisher
RTV 5.0 5 megapixel camera. All photomicrographs were
acquired at a total magnification of 4009. QCAPTURE SUITE
PLUS version 3.1.3.10 (QImaging , Surrey, BC, Canada)
was used for image acquisition. All panels were assembled
in ADOBE PHOTOSHOP CS5, version 12.0 (Adobe Systems
Incorporated, San Jose, CA 95110-2704). Processing of
images was restricted to global adjustments of brightness,
contrast and image size for each photomicrograph.
RNA isolation and expression analysis
RNA was purified from colonic tissue and gene expres-
sion was assessed as described previously.4,5,11,23,26 Briefly,
samples of colonic tissue approximately 1 cm2 were
excised from the midpoint of the colon and stored in
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RNAlater (Ambion, Austin, TX) for further analysis. To
isolate RNA, samples were homogenized in TRIzol
reagent (Life Technologies, Grand Island, NY), and RNA
was purified using the RNeasy Mini Kit (Ambion)
according to the manufacturers’ instructions. Purified
RNA was assessed for concentration and purity using a
nanodrop instrument (Thermo Fisher, Waltham, MA)
and Agilent Bioanalyzer (Agilent, Santa Clara, CA),
respectively. RNA was converted to cDNA using the RT2
first strand kit (Qiagen, Hilden, Germany) and colonic
gene expression was assessed using RT2 Profiler PCR
Assays (Qiagen). All PCR were run on a Roche LightCy-
cler 480. For RT2 Profiler PCR Assays, cross card normal-
ization was performed to control for card-to-card
variability.35 ΔCt (dCt) values were calculated by sub-
tracting the mean Ct value of two internal control genes
from the gene in question.33,36
Statistical analysis
Statistically significant differences in gene expression were
determined by performing a one-way analysis of variance
(ANOVA) with Tukey’s post-hoc test on normalized dCt
values.4,11,26 Statistically significant difference in colonic
C. difficile colonization were likewise identified by per-
forming a one-way ANOVA with Tukey’s post-hoc test on
normalized dCt values.4 A one-way ANOVA with Tukey’s
post-hoc test was also used to identify statistically signifi-
cant differences in the number of particular cellular sub-
sets per 100 000 cells. For all analyses, statistical
significance was set at P ≤ 005.
Results
Effect of IL-23 deficiency on colonic monocyte
recruitment
To investigate the role of IL-23 in promoting monocyte
recruitment during C. difficile colitis, wild-type (WT) and
IL-23KO mice were infected with C. difficile as described
previously.26 Briefly, mice were given 05 g/l cefoperazone
in their drinking water for 5 days and after a 2-day
recovery period on regular water were infected with
spores of the C. difficile strain VPI 10463 by oral gavage.
The mice were followed for an additional 2 days, at
which point the infection was terminated and all samples
were collected.
RT-PCR analysis was used to examine the effect of IL-23
deficiency on the expression of known monocyte-recruiting
chemokines in the colon following C. difficile infection.
The absence of IL-23 was associated with significantly
reduced expression of Ccl4 and Ccl7, but not Ccl2, in the
colonic mucosa in response to C. difficile infection
(Fig. 1a). The absence of IL-23 did not affect the C. difficile
burden within the colon (see Supplementary material,
Fig. S2). Flow cytometric analysis of colonic CD45+ leuco-
cytes revealed a significant reduction in the frequency of
CD11bHigh CD11cLow myeloid cells recruited to the colon
in IL-23KO mice compared with WT animals (Fig. 1b).
Subsequent analysis of the CD11bHigh CD11cLow popula-
tion demonstrated that IL-23 deficiency was also associated
with a significant defect in the recruitment of
Ly6CHigh Ly6GMid monocytes (Fig. 1c). Taken together,
these data suggest that IL-23 promotes monocyte recruit-
ment and the expression of monocyte-recruiting chemoki-
nes in the colon during C. difficile colitis.
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Figure 1. Colonic monocyte recruitment and colonic chemokine
expression during Clostridium difficile infection in interleukin-23
(IL-23) -deficient mice. (a) Colonic chemokine expression as
assessed by quantitative PCR. n ≥ 6 per group. Data are shown as
fold change in gene expression in the indicated group compared
with untreated wild-type (WT) animals. Black bars: WT C. difficile-
infected (CDI), white bars: IL-23 knockout (KO) CDI. *P < 005 for
the difference between the indicated group and untreated WT ani-
mals. Square brackets indicate P < 005 for the differences in expres-
sion levels between the indicated groups. (b) Number of
CD11bHigh CD11cLow and (c) number of Ly6CHigh Ly6GMid cells per
100 000 cells. Bars represent mean  SEM number of the indicated
cell type per 100 000 cells. n = 8 for all groups. *P < 005 for the
differences between the indicated groups.
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Colonic monocyte recruitment during C. difficile
colitis in CCR2-deficient mice
To further investigate the role of recruited monocytes
during C. difficile colitis, CCR2/ (CCR2KO) mice were
infected as described in the Materials and methods.
Clostridium difficile infection in WT animals was associ-
ated with significant recruitment of CD11bHigh CD11cLow
myeloid cells (Fig. 2a centre panel and Fig. 3a). This
CD11bHigh CD11cLow population contained both
Ly6CHigh Ly6GMid monocytes and Ly6CMid Ly6GHigh neu-
trophils, and the frequency of both these populations was
significantly increased above baseline following C. difficile
infection (Fig. 2b centre panel and Fig. 3b,c). Whereas
neither CD11bHigh CD11cLow myeloid cell nor
Ly6CMid Ly6GHigh neutrophil recruitment were signifi-
cantly altered in CCR2KO mice (Fig. 2a,b right column
and Fig. 3a,c), Ly6CHigh Ly6GMid monocyte recruitment
was significantly abrogated in CCR2KO mice infected
with C. difficile (Fig. 2b right panel, Fig. 3b). There was
no difference in the frequency of total CD45+ leucocytes
between groups (data not shown). These data indicate
that Ly6CHigh Ly6GMid monocyte recruitment, but not
CD11bHigh CD11cLow myeloid cell or Ly6CMid Ly6GHigh
neutrophil recruitment, is significantly reduced during
C. difficile colitis in the absence of CCR2 signalling.
Effect of CCR2 deficiency on inflammatory cytokine
and chemokine expression
RT-PCR analysis was used to examine the effect of CCR2
deficiency on colonic inflammatory cytokine and chemo-
kine expression in response to C. difficile colitis. Consis-
tent with the significant influx of neutrophils observed in
these animals (Figs 2b and 3c), C. difficile infection in
WT mice was associated with increased expression of the
neutrophil chemokines Ccl3, Cxcl1 and Cxcl2 (Fig. 4a).
Expression of the inflammatory cytokines Il1b, Il6, Il17f
and Tnf were all significantly increased in WT C. difficile
infected animals (Fig. 4b). Arg1, Slpi and Inos were also
significantly induced during C. difficile colitis (Fig. 4c).
CCR2 deficiency did not result in any defects in the
induction of the myeloid cell chemokines Ccl3, Cxcl1 or
Cxcl2, (Fig. 4a). Furthermore, CCR2-deficient animals
displayed no reduction in Il1b, Il6, Tnf or Arg1 expression
(Fig. 4b,c). The expression levels of Slpi and Inos, how-
ever, were significantly reduced in CCR2KO mice com-
pared with WT animals infected with C. difficile (Fig. 4c).
Consistent with the gene expression, we observed no
reduction in the severity of colonic histopathology (see
Supplementary material, Fig. S3, left and middle col-
umns) or levels of C. difficile colonization in CCR2KO
animals (see Supplementary material, Fig. S2). Addition-
ally, the absence of CCR2 was associated with a signifi-
cant decrease in ifng expression within the colonic
mucosa in response to C. difficile infection (Fig. 4d). Col-
lectively, these data suggest that while CCR2 signalling is
not required for the induction of inflammatory mediators
including Cxcl1, Cxcl2, Il1b and Il6, the full expression of
Inos and Arg1 is dependent on CCR2 signalling during
C. difficile colitis.
Effect of anti-IFN-c treatment on myeloid cell
recruitment and inflammatory cytokine expression
within the colon
To investigate the role of IFN-c in promoting monocyte
and neutrophil recruitment, as well as inflammatory
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Figure 2. Flow cytometric analysis of colonic
CD45+ leucocytes from untreated, wild-type
Clostridium difficile-infected (WT CDI), and
CCR2 knockout (KO) CDI mice. (a) Analysis
of CD11b and CD11c expression profiles on
isolated colonic CD45+ leucocytes. (b) Analysis
of Ly6C and Ly6G expression profiles on the
CD11bHigh CD11cLow population as defined in
(a). The number in bold indicates the percent-
age of the parent population contained within
the indicated gate. [Colour figure can be
viewed at wileyonlinelibrary.com]
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cytokine and chemokine expression during C. difficile
colitis, animals were treated with anti-IFN-c monoclonal
antibody 1 day before and 1 day after infection. As in
previous experiments, all samples were collected 2 days
after infection.
Analysis of CD45+ colonic leucocytes revealed no defect
in CD11bHigh CD11cLow myeloid cell recruitment in anti-
IFN-c-treated animals (Fig. 5a). Further analysis of Ly6C
and Ly6G expression within the CD11bHigh CD11cLow
myeloid cell population revealed equivalent levels of
Ly6CHigh Ly6GMid monocyte and Ly6CMid Ly6GHigh neu-
trophil recruitment following anti-IFN-c treatment
(Fig. 5b). Taken together, these data suggest that the
recruitment of inflammatory myeloid cells, including
Ly6CHigh Ly6GMid monocytes and Ly6CMid Ly6GHigh neu-
trophils is independent of IFN-c signalling during acute
C. difficile colitis.
Colonic inflammatory cytokine and chemokine expres-
sion following anti-IFN-c treatment was also examined
using RT-PCR. Anti-IFN-c treatment was associated with
significantly reduced expression of the IFN-c-inducible
chemokines Cxcl9 and Cxcl10 in response to C. difficile
infection (Fig. 6a). However, in agreement with the high
level of monocyte and neutrophil recruitment seen in
these animals, anti-IFN-c treatment did not ablate
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Figure 3. Quantification of colonic myeloid cell populations from
Untreated, wild-type Clostridium difficile-infected (WT CDI), and
CCR2 knockout (KO) CDI mice as defined in Fig. 2. (a) Number of
CD11bHigh CD11cLow, (b) Ly6CHigh Ly6GMid and (c) Ly6CMid Ly6GHigh
cells per 100 000 cells. All populations were defined as shown in Fig. 2.
Bars represent mean  SEM number of the indicated cell type per
100 000 cells. n ≥ 6 per group. CDI = C. difficile-infected. *P < 005
for the differences between the indicated groups.
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Figure 4. Inflammatory cytokine expression in wild-type (WT) and
CCR2 knockout (KO) mice infected with Clostridium difficile.
Expression of inflammatory cytokine genes in the colon was assessed
via quantitative PCR as outlined in the Materials and methods. Data
are shown as mean  SEM fold change gene expression in the indi-
cated group compared with untreated WT animals. n ≥ 7 per group.
Black bars: wild-type C. difficile-infected (WT CDI, grey bars:
CCR2KO CDI. Brackets P < 005 for the differences in expression
levels between the indicated groups. *P < 005 for the difference
between the indicated group and untreated WT animals.
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expression of Ccl3, Cxcl1, Cxcl2, Ccl2 or Ccl4 (Fig. 6b,c).
Consistently, the expression of inflammatory cytokines
including Il6 was not reduced in anti-IFN-c-treated ani-
mals (Fig. 6d). Additionally, we observed no change in
C. difficile burden or reduction in the severity of colonic
histopathology following ablation of IFN-c (see Supple-
mentary material, Figs S2 and S3).
Furthermore, induction of Arg1 and Slpi was also
unchanged following anti-IFN-c treatment (Fig. 6e). Sur-
prisingly, Inos expression was independent of anti-IFN-c
treatment as well (Fig. 6e). These data indicate that IFN-c
is not a major driver of inflammatory cytokine and che-
mokine expression within the colon during acute C. diffi-
cile infection.
Discussion
In the current study, we reported a significant reduction
in both CD11bHigh CD11cLow myeloid cell and
Ly6CHigh Ly6GMid monocyte recruitment to the colon, as
well as significant defects in the induction of the mono-
cyte chemokines Ccl4 and Ccl7, within the colonic
mucosa of IL-23KO mice. Additionally, we observed sig-
nificantly reduced monocyte recruitment in CCR2-defi-
cient mice infected with C. difficile. Despite the drastic
reduction in monocyte recruitment, the induction of
inflammatory cytokines and chemokines including Il1b,
Il6, Cxcl1 and Cxcl2 were not significantly altered in
CCR2-deficient animals. Furthermore, CCR2KO mice
were not protected from the development of severe
intestinal histopathology during C. difficile colitis. Collec-
tively, these data strongly suggest that IL-23 signalling
promotes Ly6CHigh Ly6GMid monocyte recruitment to the
colon in response to C. difficile colitis, but that the
monocytes themselves are not major drivers of inflamma-
tory cytokine expression or intestinal histopathology dur-
ing C. difficile colitis.
The reduced Ly6CHigh Ly6GMid monocyte influx seen
in CCR2KO mice infected with C. difficile was associated
with significantly reduced expression of Inos and Slpi in
the colon. Inducible nitric oxide synthase production by
CD11bHigh monocyte/macrophages has been previously
reported in the lungs following lipopolysaccharide-
mediated pulmonary inflammation.37 Ly6CHigh mono-
cytes recruited to the spleen following L. monocytogenes
infection also produce inducible nitric oxide synthase.29
Furthermore, several in vitro studies have reported Slpi
induction in macrophages following stimulation with
microbial products including lipopolysaccharide38 and
heat-killed Mycobacterium tuberculosis.39 Consistent with
these in vitro studies we observed decreased Inos and Slpi
expression in CRR2-deficient mice infected with C. diffi-
cile. However, Inos and Slpi expression were not affected
by anti-IFN-c treatment. These data suggest that
Ly6CHigh Ly6GMid monocytes are a major source of IFN-
c-independent Inos and Slpi expression in the colon in
response to C. difficile colitis.
We observed no reduction in inflammatory cytokine
or chemokine expression in CCR2KO mice during
C. difficile colitis, although Ly6CHigh Ly6GMid monocyte
recruitment was significantly reduced in these animals.
Reduction of macrophage/monocyte recruitment during
bleomycin-mediated pulmonary inflammation is associ-
ated with reduced TNF-a production in the lungs.6 Like-
wise, TNF-a+ monocyte/macrophages are recruited to
the colon in a CCR2-dependent manner during DSS col-
itis.7 Furthermore, a recent study has suggested that
Ly6CHigh monocytes are largely responsible for colonic
IL-6, IL-1b and IFN-c production during DSS colitis.9
Specific to C. difficile, stimulation of monocytes with
C. difficile toxins in vitro results in rapid production
of inflammatory cytokines including IL-8, IL-1b and
TNF-a.40,41 However, in the current study there was no
reduction in inflammatory cytokine expression in CCR2-
deficient mice infected with C. difficile, suggesting that
Ly6CHigh Ly6GMid monocytes are not a major source of
inflammatory cytokine expression in the colon during
acute C. difficile colitis.
Despite significantly reduced levels of Ly6CHigh Ly6GMid
monocyte influx, CCR2KO mice were not protected against
WT CDI CDI + anti-IFN-γ
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Figure 5. Flow cytometric analysis of colonic CD45+ leucocytes from
wild-type Clostridium difficile-infected (WT CDI), and CDI+ anti-
interferon-c (IFN-c) -treated mice. (a) Analysis of CD11b and CD11c
expression profiles on isolated colonic CD45+ leucocytes. (b) Analysis
of Ly6C and Ly6G expression profiles on the CD11bHigh CD11cLow
population as defined in (a). The number in bold indicates the per-
centage of the parent population contained within the indicated gate.
[Colour figure can be viewed at wileyonlinelibrary.com]
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the development of severe colonic inflammation and
histopathology in response to C. difficile colitis. Numerous
studies have reported reduced intestinal histopathology
during DSS colitis following interference with CCR2-
dependent monocyte influx.8,9 Furthermore, robust mono-
cyte/macrophage recruitment has been previously reported
during C. difficile infection in association with marked
intestinal histopathology.2–5,10 A previous study from our
group also reported no decrease in the severity of intestinal
histopathology following the depletion of both monocyte
and neutrophil populations by anti-Gr-1 monoclonal anti-
body treatment.4 In the current study we report no protec-
tion from robust intestinal histopathology in CCR2KO
mice. Hence, the data presented here suggest that Ly6CHigh
Ly6GMid monocytes are not major drivers of intestinal
histopathology during acute C. difficile colitis.
We report no reduction in monocyte and neutrophil
recruitment or decreased inflammatory cytokine expres-
sion following anti-IFN-c treatment. IFN-c drives neu-
trophil recruitment in response to insult at mucosal
sites,19–21 and IFN-c+ neutrophil influx has recently been
reported in response to Salmonella typhimurium typhlo-
colitis22 as well as C. difficile colitis.15 Specific to the
colon, neutrophil recruitment and CCL2 production dur-
ing DSS colitis are both dependent upon IFN-c.19 Addi-
tionally, CXCL1 expression and neutrophil recruitment to
the ileum were blunted in response to C. difficile toxin A
in IFN-cKO mice.21 Furthermore, a recent study has
highlighted the crucial role of type 1 innate lymphoid
cells for host survival during experimental C. difficile
infection.24 However, in the current study, we observed
no defect in myeloid cell recruitment or expression of Il6
and Il17f following anti-IFN-c treatment, suggesting that
innate IFN-c protects the host from mortality through
other mechanisms.
One potential interpretation of the data presented in the
current study is that IFN-c is largely redundant in the host
response to C. difficile colitis. However, a recent study by
Abt et al. has reported a marked defect in the induction of
IFN-c in association with decreased survival in mice lack-
ing Tbet+ type 1 innate lymphoid cells cells following chal-
lenge with C. difficile.24 Additionally, Rag/ IFN-c/
mice also demonstrated a large increase in mortality,
strongly suggesting that innate IFN-c signalling is critical
for host survival in response to C. difficile infection.24
Collectively, these data suggest that IFN-c is protective
during C. difficile colitis via mechanisms independent of
inflammatory cytokine expression and granulocyte
recruitment.
We observed significantly reduced CD11bHigh CD11cLow
myeloid cell and Ly6CHigh Ly6GMid monocyte recruitment
to the colon during C. difficile colitis in IL-23-deficient
mice. Interleukin-23 has been previously demonstrated to
drive TNFa+ inflammatory monocyte recruitment to the
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Figure 6. Effect of anti-interferon-c (IFN-c)
treatment on colonic inflammatory cytokine
and chemokine expression. Data are shown as
mean  SEM fold change gene expression in
the indicated group compared with untreated
wild-type (WT) animals. n ≥ 4 per group.
CDI = Clostridium difficile-infected. Black bars:
WT CDI, light grey bars: CDI+ anti-IFN-c.
Brackets P < 005 for the differences in expres-
sion levels between the indicated groups.
*P < 005 for the difference between the indi-
cated group and untreated WT animals.
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spleen in response to Listeria monocytogenes infection.29
Specific to colonic inflammation, IL-23 signalling pro-
motes CD11bHigh myeloid cell recruitment during chemi-
cally induced colitis.25 We report significantly reduced
Ly6CHigh Ly6GMid monocyte recruitment and expression
of the monocyte chemotactic factors Ccl4 and Ccl7 in IL-
23-deficient mice during C. difficile colitis. Hence, our
data strongly suggest that IL-23 signalling drives monocyte
recruitment to the colon in response to C. difficile
infection.
One model which explains our observations is that
IL-23 promotes the expression of the monocyte chemoki-
nes Ccl4 and Ccl7, but not Ccl2, contributing to the
recruitment of Ly6CHigh Ly6GMid monocytes to the colon.
These recruited monocytes are not required for the
induction of inflammatory cytokines and chemokines
including Cxcl1, Cxcl2 and Il1b or the development of
severe intestinal histopathology, but are required for full
expression of Slpi and Inos within the colon.
A previous study from our laboratory reported reduced
neutrophil recruitment and inflammatory cytokine and
chemokine expression in the absence of IL-23 signalling,26
whereas an additional study noted no decrease in the
severity of intestinal histopathology or inflammatory
cytokine expression following the concomitant depletion
of monocytes and neutrophils.4 Taken together, these
studies strongly suggest that (i) IL-23 is required for the
recruitment of numerous myeloid populations including
monocytes and neutrophils during C. difficile colitis, (ii)
monocytes and neutrophils are not major drivers of
intestinal histopathology or inflammatory cytokine
expression during C. difficile infection, and (iii) the
reduced intestinal histopathology and inflammatory cyto-
kine production seen in IL-23KO mice is independent of
the reduced neutrophil and monocyte recruitment in
these animals. Hence, IL-23-responsive host cells other
than recruited myeloid populations are the main sources
of inflammatory cytokine expression in the colon during
C. difficile colitis.
Recent studies have reported a protective role of innate
IFN-c24 and a therapeutic benefit for enhanced eosinophil
recruitment17 in response to C. difficile infection, strongly
suggesting a protective role for Type 1 and Type 2
responses, respectively. The role for Type 17 responses,
and specifically the role of the Type 17-promoting cyto-
kine IL-23, remains more difficult to define. Interleukin-
23 has been implicated in driving severe intestinal
histopathology and mortality during C. difficile infec-
tion,18,26 suggesting that interference with IL-23 signalling
would be of therapeutic benefit to patients with clinical
C. difficile infection. However, neutrophil recruitment, a
host response repeatedly demonstrated to be critical for
survival during C. difficile infection,3,10 is also signifi-
cantly reduced in the absence of IL-23 signalling,26 As
such, interference with IL-23 signalling may ultimately
worsen disease by impairing protective neutrophil recruit-
ment, in addition to increasing the susceptibility of the
patient to other infections. Therefore, any immunomodu-
latory treatment for C. difficile infection, either a biologi-
cally or microbiota-based method, should seek to
diminish the pathological aspects of IL-23 signalling while
still retaining robust neutrophil recruitment. Future stud-
ies will focus on better understanding the inflammatory
cascades driven by IL-23, with the ultimate goals of iden-
tifying IL-23-dependent host signals that promote
histopathology and disease development but not neu-
trophil recruitment.
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